These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37214019)

  • 1. Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis.
    Palot Manzil FF; Pandey T
    Cureus; 2023 Apr; 15(4):e37838. PubMed ID: 37214019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
    Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
    Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis.
    Velaga J; Liew C; Choo Poh AC; Lee PT; Lath N; Low SC; Bharadwaj P
    World J Nucl Med; 2022 Sep; 21(3):173-183. PubMed ID: 36060088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Evaluation of Cardiac Amyloidosis with Noninvasive Multimodality Imaging.
    Wang J; Wang Y; Ren S; Chen Y; Chu H; Pang Z; Li J
    Int Heart J; 2022 Nov; 63(6):1194-1200. PubMed ID: 36372411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
    Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
    JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
    Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
    Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.
    Jung MH; Chang S; Han EJ; Youn JC
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.
    Castaño A; Manson DK; Maurer MS; Bokhari S
    Curr Cardiovasc Risk Rep; 2017 Jun; 11():. PubMed ID: 29057029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Amyloidosis: Current Diagnostic Strategies Using Multimodality Imaging.
    Fukushima K; Nakano S; Matsunari I
    Ann Nucl Cardiol; 2020; 6(1):67-73. PubMed ID: 37123486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear imaging techniques for cardiac amyloidosis.
    Saad JM; Al-Mallah MH
    Curr Opin Cardiol; 2024 Jul; ():. PubMed ID: 38967657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Tracers for the Imaging of Cardiac Amyloidosis.
    Shetty M; Malhotra S
    J Nucl Med Technol; 2023 Jun; 51(2):120-124. PubMed ID: 37192820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
    Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
    Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements and challenges in cardiac amyloidosis imaging: A comprehensive review of novel techniques and clinical applications.
    Albulushi A; Al Hajri R; Hovseth C; Jawa Z; El Hadad MG; Sallam M; Al-Mukhaini M
    Curr Probl Cardiol; 2024 Jun; 49(9):102733. PubMed ID: 38955249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
    Martini N; Rizzo S; Sarais C; Cipriani A
    BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of nuclide scintigraphy in the diagnosis and prognosis of cardiac amyloidosis.
    Mo Q; Deng Z; Xiao Y; Liu C; Zhao M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1739-1745. PubMed ID: 38432865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic imaging of cardiac amyloidosis.
    Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
    Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.